CAPS - Capstone Therapeutics Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development1,0411,1823,071
Selling General and Administrative5431,7571,453
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-1,584-2,939-4,524
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes-1,665-2,963-4,567
Interest Expense---
Income Before Tax-1,665-2,963-4,567
Income Tax Expense-56-192-400
Minority Interest---
Net Income From Continuing Ops-663-2,771-4,167
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-663-2,771-4,167
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-663-2,771-4,167